Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019

Atrial fibrillation is a common clinical manifestation in hospitalized patients with coronavirus disease 2019 (COVID‐19). Medications used to treat atrial fibrillation, such as antiarrhythmic drugs and anticoagulants, may have significant drug interactions with emerging COVID‐19 treatments. Common u...

Descripción completa

Detalles Bibliográficos
Autores principales: Rattanawong, Pattara, Shen, Win, El Masry, Hicham, Sorajja, Dan, Srivathsan, Komandoor, Valverde, Arturo, Scott, Luis R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Contemporary Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660727/
https://www.ncbi.nlm.nih.gov/pubmed/32515253
http://dx.doi.org/10.1161/JAHA.120.017529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660727/
https://www.ncbi.nlm.nih.gov/pubmed/32515253
http://dx.doi.org/10.1161/JAHA.120.017529

Ejemplares similares